Phio Pharmaceuticals(PHIO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PHIO Phio Pharmaceuticals

交易中 12-23 11:02:33 EST

2.61

+0.85

+48.30%

最高2.97	最低2.15	成交量908.05万
今开2.66	昨收1.76	日振幅46.59%
总市值389.52万	流通市值389.52万	总股本149.24万
成交额2,270万	换手率608.44%	流通股本149.24万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"PHIO","market":"US","secType":"STK","nameCN":"Phio Pharmaceuticals","latestPrice":2.61,"timestamp":1734969737281,"preClose":1.76,"halted":0,"volume":9080457,"delay":0,"floatShares":1492411,"shares":1492411,"eps":-21.34513,"marketStatus":"交易中","marketStatusCode":2,"change":0.85,"latestTime":"12-23 11:02:33 EST","open":2.66,"high":2.9699,"low":2.15,"amount":22700274.4083108,"amplitude":0.465852,"askPrice":2.63,"askSize":50,"bidPrice":2.6,"bidSize":300,"shortable":3,"etf":0,"ttmEps":-21.34513,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1734987600000},"adr":0,"adjPreClose":1.76,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":2.62,"preClose":1.76,"latestTime":"09:29 EST","volume":1256152,"amount":4629749.6827808,"timestamp":1734964193879},"postHourTrading":{"tag":"盘后","latestPrice":1.6601,"preClose":1.76,"latestTime":"19:57 EST","volume":4028,"amount":6865.54,"timestamp":1734742678123},"volumeRatio":29.582235,"impliedVol":2.2675,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/PHIO/wiki","defaultTab":"wiki","newsList":[{"id":"2493476509","title":"Phio Pharmaceuticals Corp.股价拉升53.07% 市值涨150.88万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493476509","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493476509?lang=zh_cn&edition=full","pubTime":"2024-12-23 22:31","pubTimestamp":1734964319,"startTime":"0","endTime":"0","summary":"北京时间2024年12月23日22时31分，Phio Pharmaceuticals Corp.股票出现异动，股价急速上涨53.07%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Traws Pharma, Inc.、Gt Biopharma, Inc.、Rapt Therapeutics, Inc.涨幅较大，Phio Pharmaceuticals Corp.、Gt Biopharma, Inc.、Traws Pharma, Inc.较为活跃，换手率分别为658.46%、436.34%、277.72%，振幅较大的相关个股有Traws Pharma, Inc.、Neurosense Therapeutics Ltd.、Gt Biopharma, Inc.，振幅分别为36.65%、19.04%、17.19%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223223200a2050ab1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223223200a2050ab1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2492448294","title":"Phio Pharmaceuticals Corp.盘中异动 大幅下挫5.29%报1.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492448294","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492448294?lang=zh_cn&edition=full","pubTime":"2024-12-20 22:32","pubTimestamp":1734705145,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日22时32分，Phio Pharmaceuticals Corp.股票出现波动，股价大幅下跌5.29%。截至发稿，该股报1.65美元/股，成交量3.184万股，换手率3.02%，振幅0.86%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为0.20%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223225984cfc18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223225984cfc18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2492151345","title":"Phio Pharmaceuticals Corp.盘中异动 股价大跌5.19%报2.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492151345","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492151345?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:45","pubTimestamp":1734554756,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时45分，Phio Pharmaceuticals Corp.股票出现波动，股价快速下挫5.19%。截至发稿，该股报2.56美元/股，成交量1.8574万股，换手率1.76%，振幅8.97%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为3.05%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219044556984cb930&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219044556984cb930&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2492645549","title":"Phio Pharmaceuticals Corp.盘中异动 早盘急速下跌6.69%报2.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492645549","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492645549?lang=zh_cn&edition=full","pubTime":"2024-12-17 23:31","pubTimestamp":1734449483,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日23时31分，Phio Pharmaceuticals Corp.股票出现异动，股价急速下挫6.69%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.52%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217233124984c9183&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217233124984c9183&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2490664384","title":"Phio Pharmaceuticals Corp.盘中异动 大幅拉升5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490664384","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490664384?lang=zh_cn&edition=full","pubTime":"2024-12-12 22:33","pubTimestamp":1734014016,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日22时33分，Phio Pharmaceuticals Corp.股票出现波动，股价快速拉升5.18%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为0.16%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212223336ab72a954&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212223336ab72a954&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2490627658","title":"Phio Pharmaceuticals Corp.盘中异动 大幅下挫5.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490627658","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490627658?lang=zh_cn&edition=full","pubTime":"2024-12-12 00:20","pubTimestamp":1733934008,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日00时20分，Phio Pharmaceuticals Corp.股票出现波动，股价急速下跌5.87%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为0.48%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121200200995e8fcd0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121200200995e8fcd0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2489239709","title":"Phio Pharmaceuticals Corp.盘中异动 急速拉升5.54%报2.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489239709","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489239709?lang=zh_cn&edition=full","pubTime":"2024-12-06 22:31","pubTimestamp":1733495483,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日22时31分，Phio Pharmaceuticals Corp.股票出现异动，股价大幅上涨5.54%。截至发稿，该股报2.86美元/股，成交量1327股，换手率0.13%，振幅0.00%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.29%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206223123a1d96ea1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206223123a1d96ea1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2489727461","title":"Phio Pharmaceuticals Corp.盘中异动 早盘股价大跌5.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489727461","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489727461?lang=zh_cn&edition=full","pubTime":"2024-12-05 23:48","pubTimestamp":1733413680,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日23时48分，Phio Pharmaceuticals Corp.股票出现异动，股价急速跳水5.74%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.35%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205234801a1d6c0f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205234801a1d6c0f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2488394425","title":"Phio Pharmaceuticals Corp.盘中异动 股价大跌6.51%报2.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488394425","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488394425?lang=zh_cn&edition=full","pubTime":"2024-12-03 23:34","pubTimestamp":1733240057,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日23时34分，Phio Pharmaceuticals Corp.股票出现异动，股价快速跳水6.51%。截至发稿，该股报2.73美元/股，成交量804股，换手率0.08%，振幅0.00%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为0.51%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203233417a269b624&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203233417a269b624&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2486827292","title":"Phio Pharmaceuticals Corp.盘中异动 早盘股价大涨5.13%报2.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486827292","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486827292?lang=zh_cn&edition=full","pubTime":"2024-11-27 22:31","pubTimestamp":1732717864,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日22时31分，Phio Pharmaceuticals Corp.股票出现波动，股价大幅上涨5.13%。截至发稿，该股报2.64美元/股，成交量1570股，换手率0.15%，振幅0.80%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.22%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112722310498e44e7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112722310498e44e7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2485421200","title":"Phio Pharmaceuticals Corp.2024财年第三财季实现净利润-1.52百万美元，同比增加45.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485421200","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485421200?lang=zh_cn&edition=full","pubTime":"2024-11-24 00:00","pubTimestamp":1732377619,"startTime":"0","endTime":"0","summary":"11月24日，Phio Pharmaceuticals Corp.公布财报，公告显示公司2024财年第三财季净利润为-1.52百万美元，同比增加45.32%；其中营业收入为0.00美元，每股基本收益为-1.54美元。机构评级：截至2024年11月24日，当前有1家机构对Phio Pharmaceuticals Corp.目标价做出预测，其中目标均价为36.00美元，其中最低目标价为36.00美元，最高目标价为36.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241124000028abd9b88c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241124000028abd9b88c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO"],"gpt_icon":0},{"id":"2485127644","title":"Phio Pharmaceuticals Corp.盘中异动 临近午盘急速上涨7.17%报2.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485127644","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485127644?lang=zh_cn&edition=full","pubTime":"2024-11-22 00:52","pubTimestamp":1732207932,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日00时52分，Phio Pharmaceuticals Corp.股票出现波动，股价大幅拉升7.17%。截至发稿，该股报2.55美元/股，成交量2.0868万股，换手率1.98%，振幅4.62%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.01%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122005212abd5224a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122005212abd5224a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2484592986","title":"Phio Pharmaceuticals Corp.盘中异动 早盘快速拉升5.29%报2.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484592986","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484592986?lang=zh_cn&edition=full","pubTime":"2024-11-19 23:16","pubTimestamp":1732029400,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日23时16分，Phio Pharmaceuticals Corp.股票出现异动，股价快速上涨5.29%。截至发稿，该股报2.39美元/股，成交量6.1335万股，换手率7.13%，振幅4.85%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为1.28%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111923164098e4388c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111923164098e4388c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2483370325","title":"Phio Pharmaceuticals Corp.盘中异动 早盘大幅拉升9.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483370325","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483370325?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:31","pubTimestamp":1731681079,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日22时31分，Phio Pharmaceuticals Corp.股票出现波动，股价急速上涨9.87%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为0.69%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111522311995be3400&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111522311995be3400&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2483345423","title":"Phio Pharmaceuticals Corp.盘中异动 快速下跌5.11%报2.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483345423","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483345423?lang=zh_cn&edition=full","pubTime":"2024-11-15 04:25","pubTimestamp":1731615942,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日04时25分，Phio Pharmaceuticals Corp.股票出现异动，股价急速跳水5.11%。截至发稿，该股报2.23美元/股，成交量2.6434万股，换手率3.07%，振幅9.67%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为1.40%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115042542971a6a1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115042542971a6a1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2483345458","title":"Phio Pharmaceuticals Corp.盘中异动 临近午盘股价大跌5.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483345458","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483345458?lang=zh_cn&edition=full","pubTime":"2024-11-14 00:58","pubTimestamp":1731517134,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日00时58分，Phio Pharmaceuticals Corp.股票出现异动，股价快速跳水5.86%。截至发稿，该股报2.41美元/股，成交量7722股，换手率0.90%，振幅5.86%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为0.20%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114005854abbe2f48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114005854abbe2f48&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2482738392","title":"Phio Pharmaceuticals Corp.盘中异动 早盘快速下挫6.78%报2.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482738392","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482738392?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:40","pubTimestamp":1731336004,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时40分，Phio Pharmaceuticals Corp.股票出现波动，股价急速跳水6.78%。截至发稿，该股报2.75美元/股，成交量7872股，换手率0.91%，振幅8.48%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为0.09%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111224005a22ce8fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111224005a22ce8fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2482709436","title":"Phio Pharmaceuticals Corp.盘中异动 下午盘大幅跳水5.23%报3.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482709436","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482709436?lang=zh_cn&edition=full","pubTime":"2024-11-09 02:26","pubTimestamp":1731090385,"startTime":"0","endTime":"0","summary":"北京时间2024年11月09日02时26分，Phio Pharmaceuticals Corp.股票出现异动，股价急速下挫5.23%。截至发稿，该股报3.08美元/股，成交量2.9604万股，换手率3.44%，振幅8.00%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为1.03%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109022625a2253f36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109022625a2253f36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2481660407","title":"Phio Pharmaceuticals Corp  预计每股亏损 4.14 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481660407","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481660407?lang=zh_cn&edition=full","pubTime":"2024-11-06 21:56","pubTimestamp":1730901362,"startTime":"0","endTime":"0","summary":"Phio Pharmaceuticals Corp  预计每股亏损 4.14 美元 - 财报前瞻Phio Pharmaceuticals Corp PHIO.OQ PHIO.O预计将于11月7日公布截至2024年9月30日的财报(预计) LSEG 的分析师平均预计 Phio Pharmaceuticals Corp 每股亏损 4.14 美元。华尔街对 Phio Pharmaceuticals Corp 的 12 个月目标股价中位数为 36.00 美元，高于上一交易日的收盘价 3.26 美元。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241106:nL4S3MD27O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHIO"],"gpt_icon":0},{"id":"2480063928","title":"Phio Pharmaceuticals Corp.盘中异动 股价大跌7.62%报2.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480063928","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480063928?lang=zh_cn&edition=full","pubTime":"2024-11-01 03:13","pubTimestamp":1730401992,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日03时13分，Phio Pharmaceuticals Corp.股票出现波动，股价大幅下跌7.62%。截至发稿，该股报2.91美元/股，成交量2.598万股，换手率3.02%，振幅6.03%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为3.38%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110103131298e3fc94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110103131298e3fc94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.phiopharma.com","stockEarnings":[{"period":"1week","weight":-0.3737},{"period":"1month","weight":-0.2605},{"period":"3month","weight":-0.5},{"period":"6month","weight":-0.7145},{"period":"1year","weight":-0.7456},{"period":"ytd","weight":-0.7427}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Phio Pharmaceuticals Corp.是一家生物技术公司，基于公司专有的新一代核糖核酸干扰(RNAi)平台专注于发现、开发和商业化创新疗法。由于这些疗法得“沉默”能力,或者说是其下调能力,病态情况下的特定基因可以被分析的更为清楚，所以基于RNAi平台的疗法更有说服力的。2011年9月8日之前,该公司的业务由其非操作部门Galena Biopharma公司（该公司的前母公司）来完成。公司成立于特拉华州，作为Galena 的全资子公司。2011年9月8日开始，其计划并准备与Galena脱离。2012年4月27日这一计划得以完成。至此之后,公司作为一个独立的上市公司运营。","yearOnYearQuotes":[{"month":1,"riseRate":0.3,"avgChangeRate":-0.062312},{"month":2,"riseRate":0.4,"avgChangeRate":-0.033019},{"month":3,"riseRate":0.454545,"avgChangeRate":-0.080586},{"month":4,"riseRate":0.272727,"avgChangeRate":-0.121062},{"month":5,"riseRate":0.272727,"avgChangeRate":-0.038426},{"month":6,"riseRate":0.454545,"avgChangeRate":-0.020605},{"month":7,"riseRate":0.363636,"avgChangeRate":-0.103097},{"month":8,"riseRate":0.272727,"avgChangeRate":-0.030187},{"month":9,"riseRate":0.090909,"avgChangeRate":-0.131629},{"month":10,"riseRate":0.272727,"avgChangeRate":-0.131123},{"month":11,"riseRate":0.363636,"avgChangeRate":-0.063336},{"month":12,"riseRate":0.181818,"avgChangeRate":-0.146113}],"exchange":"NASDAQ","name":"Phio Pharmaceuticals","nameEN":"Phio Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Phio Pharmaceuticals(PHIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Phio Pharmaceuticals(PHIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Phio Pharmaceuticals,PHIO,Phio Pharmaceuticals股票,Phio Pharmaceuticals股票老虎,Phio Pharmaceuticals股票老虎国际,Phio Pharmaceuticals行情,Phio Pharmaceuticals股票行情,Phio Pharmaceuticals股价,Phio Pharmaceuticals股市,Phio Pharmaceuticals股票价格,Phio Pharmaceuticals股票交易,Phio Pharmaceuticals股票购买,Phio Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Phio Pharmaceuticals(PHIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Phio Pharmaceuticals(PHIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}